NYSE: CCJCameco Corp Stock
$107.92-7.38 (-6.4%)
Updated Mar 13, 2026
CCJ Price
$107.92
Fair Value Price
N/A
Market Cap
$46.98B
52 Week Low
$35.00
52 Week High
$135.24
P/E
108.68x
P/B
9.26x
P/S
15.67x
PEG
2.3x
Dividend Yield
N/A
Revenue
$2.56B
Earnings
$430.35M
Gross Margin
27.9%
Operating Margin
25.63%
Profit Margin
16.9%
Debt to Equity
0.49
Operating Cash Flow
$1B
Beta
1.32
Next Earnings
May 1, 2026
Ex-Dividend
N/A
Next Dividend
N/A
CCJ Overview
Cameco Corporation is a uranium mining company with operations in Canada and Kazakhstan. Its McArthur River-Key Lake holding is the world's largest uranium mine. Its Cigar Lake is the world's highest-grade uranium mine. Both are located in Saskatchewan. Formerly Canadian Mining and Energy Corp., Cameco was incorporated in 1988 and is headquartered in Saskatchewan, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CCJ's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Uranium
Industry Rating
F
CCJ
Ranked#2 of 12
Ranked#2 of 12
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $3.80 | C | |
| $1.64 | C | |
| $18.67 | D |
Be the first to know about important CCJ news, forecast changes, insider trades & much more!
CCJ News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CCJ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CCJ ($107.92) is trading above its intrinsic value of $21.88, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CCJ is poor value based on its earnings relative to its share price (108.68x), compared to the US market average (31.82x)
P/E vs Market Valuation
CCJ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CCJ due diligence checks available for Premium users.
Valuation
CCJ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
108.68x
Industry
57.64x
Market
31.82x
CCJ is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CCJ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CCJ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.26x
Industry
7.38x
CCJ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CCJ price to earnings growth (PEG)
For valuing profitable companies with growth potential
CCJ is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CCJ's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CCJ's Earnings (EBIT) of $656.23M... subscribe to Premium to read more.
Interest Coverage Financials
CCJ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.5B
Liabilities
$2.5B
Debt to equity
0.49
CCJ's short-term assets ($1.94B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CCJ's short-term assets ($1.94B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CCJ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CCJ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
CCJ's operating cash flow ($1.04B)... subscribe to Premium to read more.
Debt Coverage Financials
CCJ vs Uranium Stocks
Cameco Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.